サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1089965

マイクロキャリア市場の規模、シェア、動向分析：製品別、用途別、エンドユーザー別、地域別展望、競合戦略、2030年までのセグメント別予測

Microcarrier Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 237 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
マイクロキャリア市場の規模、シェア、動向分析：製品別、用途別、エンドユーザー別、地域別展望、競合戦略、2030年までのセグメント別予測
出版日: 2022年06月14日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 237 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のマイクロキャリアの市場規模は、今後10.2%のCAGRで拡大し、2030年までに40億7,000万米ドルに達すると予測されています。気候変動や人口増加により、ウイルス発生のリスクが高まっています。このため、マイクロキャリア市場の成長の機会となっています

当レポートでは、世界のマイクロキャリア市場について調査し、市場の概要とともに、製品別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 成長要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 市場の機会
    • 課題
  • COVID-19がマイクロキャリア市場に及ぼす影響

第5章 市場変数と見通し

  • SWOT分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • ヒートマップ分析

第6章 世界のマイクロキャリア市場、製品別、2019年～2030年（100万米ドル）

  • 消耗品
    • 培地
    • 試薬
    • マイクロキャリア
  • 装置
    • バイオリアクター
    • 培養容器
    • ろ過および分離装置
    • セルカウンター
    • その他

第7章 世界のマイクロキャリア市場、用途別、2019年～2030年（100万米ドル）

  • バイオ医薬品生産
    • ワクチン生産
    • 治療用タンパク質生産
  • 細胞・遺伝子治療
  • 組織工学および再生医療
  • その他

第8章 世界のマイクロキャリア市場、エンドユーザー別、2019年～2030年（100万米ドル）

  • 製薬会社・バイオテクノロジー企業
  • CRO、CMO
  • 学術研究機関
  • セルバンク

第9章 世界のマイクロキャリア市場、地域別、2019年～2030年（100万米ドル）

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第10章 企業プロファイル

  • BD
  • CESCO Bioengineering
  • ChemoMetec
  • Corning
  • Danaher Corporation
  • Eppendorf AG
  • Fischer Scientific
  • HiMedia Laboratories
  • Merck
  • Sartorius AG
目次
Product Code: BIOT2231

Global microcarrier market is projected to be worth USD 4.07 billion by 2030.

According to SPER Market Research, the microcarrier market is estimated to reach USD 4.07 billion by 2030 with a CAGR of 10.2%. There is higher risk of virus outbreak due to climate change and increasing population. This creates opportunities for microcarrier market to grow.

Impact of COVID-19 on the Microcarrier Market

The outburst of COVID-19 infections at global level forced the governments to declare nation-wide lockdowns and norms for social distancing. The small and large players in pharmaceuticals focused on developing vaccines and other therapies against SARS-CoV-2 Research and development quickly escalated and were largely unaffected by the lockdowns and restrictions due to the support and funding. Demand for cell culture products also increased including microcarrier products. Cell culture is an important part of vaccine development which has increased the demand for microcarrier products.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Product, By Application, By End User
  • Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa
  • Companies Covered: BD, CESCO Bioengineering, ChemoMetec, Corning, Danaher Corporation, Eppendorf AG, Fischer Scientific, HiMedia Laboratories, Merck, Sartorius AG

Driver: Increasing demand for cell-based vaccines

Rapidly increasing population, close proximity between animals and humans have created favorable conditions for virus outbreaks. This increases the demand for cell culture to develop cell-based vaccines. There is a higher risk of a pandemic in future creating urgent need for cell-based vaccines due to higher efficiency, large production capacity and shorter lead time. Clinical studies have also suggested cell-based vaccines as safe and effective for use in humans.

Restraints: High research and development cost

R&D in cell biology is an expensive process involving reagents and equipment of higher quality and precision in results. The high-quality standards issued by regulatory authorities increases the cost of the research. Thus, small players and academic institutes cannot afford to carry out this research which restraints the growth of this market in the forecast period.

Opportunity: Rising demand for monoclonal antibody

Monoclonal antibodies are increasing in demand for targeted delivery for cancer treatments and immune diseases. The monoclonal antibodies are administered at higher doses thus, production is also required equally high. This creates growth opportunities for microcarriers.

Microcarrier Market by Product:

Based on product, market has been segmented into Consumables (Media [Sera/Serum-based Media, Serum-free Media, Other Media], Reagents, Microcarriers [Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers]), Equipment (Bioreactors [Single-use Bioreactors, Stainless-steel Bioreactors], Culture Vessels, Filtration and Separation Equipment, Cell Counters, Other Equipment)

Microcarrier Market by Application:

Based on application, the market is segmented into Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications

Microcarrier Market by End User:

Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Cell Banks

Pharmaceutical & Biotechnological companies have the largest share of this market by end user due to changing regulatory scenarios of cell-based vaccines and rising awareness for cell-based vaccines for its benefits.

Microcarrier Market by Region:

North America owns the largest share of this market owing to increasing R&D activities, technological advancements, increasing investments and funding in cell-based research and presence of leading players of this market.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact of the Microcarrier Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Microcarrier Market, By Product, 2019-2030 (USD Million)

  • 6.1. Consumables
    • 6.1.1. Media
      • 6.1.1.1. Sera/Serum-based Media
      • 6.1.1.2. Serum-free Media
      • 6.1.1.3. Other Media
    • 6.1.2. Reagents
    • 6.1.3. Microcarriers
      • 6.1.3.1. Collagen-coated Microcarriers
      • 6.1.3.2. Cationic Microcarriers
      • 6.1.3.3. Protein-coated Microcarriers
      • 6.1.3.4. Untreated Microcarriers
      • 6.1.3.5. Other Microcarriers
  • 6.2. Equipment
    • 6.2.1. Bioreactors
      • 6.2.1.1. Single-use Bioreactors
      • 6.2.1.2. Stainless-steel Bioreactors
    • 6.2.2. Culture Vessels
    • 6.2.3. Filtration and Separation Equipment
    • 6.2.4. Cell Counters
    • 6.2.5. Other Equipment

7. Global Microcarrier Market, By Application, 2019-2030 (USD Million)

  • 7.1. Biopharmaceutical Production
    • 7.1.1. Vaccine Production
    • 7.1.2. Therapeutic Protein Production
  • 7.2. Cell and Gene Therapy
  • 7.3. Tissue Engineering and Regenerative Medicine
  • 7.4. Other Applications

8. Global Microcarrier Market, By End User, 2019-2030 (USD Million)

  • 8.1. Pharmaceutical & Biotechnology Companies
  • 8.2. Contract Research Organizations & Contract Manufacturing Organizations
  • 8.3. Academic & Research Institutes
  • 8.4. Cell Banks

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments